指南与共识消化、代谢与肾脏急症

急诊科对接受HIV暴露后预防的体液暴露患者的管理:对澳大利亚指南推荐的依从性

Emergency Department Management of Body-Fluid Exposures Receiving Human Immunodeficiency Virus Post-Exposure Prophylaxis: Adherence to Australian Guideline Recommendations.
指南 / 共识 · Emerg Med Australas · 2026-01-01
一句话结论双中心回顾性队列显示,77例接受HIV暴露后预防者中规范随访记录达94.8%、一线方案达79.2%,但完整推荐管理仅10.4%、完整基线检查仅13.0%。

该研究为回顾性双中心队列,纳入2020年6月1日至2025年6月1日澳大利亚两家急诊科连续发药的全部HIV暴露后预防患者,排除已知HIV感染者及经专门性侵处置路径管理者。77例中,临床医生记录随访计划或转诊73例(94.8%),接受适用指南推荐一线方案61例(79.2%),但完整推荐管理记录仅8例(10.4%)、暴露风险评估36例(46.8%)、完整基线检查仅10例(13.0%)。与职业暴露及其他社区暴露相比,合意性暴露的暴露风险评估记录更低(36.2% vs 78.9%;OR 0.16,95%CI 0.03-0.57),完整基线检查也更低(5.2% vs 36.8%;OR 0.10,95%CI 0.01-0.50)。作者认为应前瞻性评估结构化急诊体液暴露路径。

要点

  • 77例接受HIV暴露后预防者中,完整推荐管理记录仅8例(10.4%),完整基线检查仅10例(13.0%)。
  • 随访计划或转诊记录73例(94.8%),接受适用指南一线方案61例(79.2%),方案与随访记录较好。
  • 合意性暴露的暴露风险评估记录36.2% vs 职业及其他社区暴露78.9%(OR 0.16,95%CI 0.03-0.57)。
  • 合意性暴露的完整基线检查5.2% vs 职业及其他社区暴露36.8%(OR 0.10,95%CI 0.01-0.50)。
  • 作者认为应前瞻性评估结构化急诊体液暴露路径。

适用人群与场景

  • 澳大利亚两家急诊科2020年6月1日至2025年6月1日连续发药的全部HIV暴露后预防患者,共77例。
  • 排除已知HIV感染者及经专门性侵处置路径管理者。

研究设计与关键结果

  • 研究类型:回顾性双中心队列研究;样本量77例;人群为两家澳大利亚急诊科接受HIV暴露后预防发药者。
  • 主要观察指标为病历记录的暴露风险评估、适用的基线检查、抗逆转录病毒方案、咨询、出院信息及临床医生记录的随访计划或转诊。
  • 随访计划或转诊记录73例(94.8%);接受适用指南一线方案61例(79.2%);完整推荐管理记录8例(10.4%);暴露风险评估记录36例(46.8%);完整基线检查10例(13.0%)。
  • 与职业暴露及其他社区暴露相比,合意性暴露的暴露风险评估记录更低(36.2% vs 78.9%;OR 0.16,95%CI 0.03-0.57)。
  • 与职业暴露及其他社区暴露相比,合意性暴露的完整基线检查更低(5.2% vs 36.8%;OR 0.10,95%CI 0.01-0.50)。

证据类型、等级与局限

  • 证据类型:回顾性双中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为应前瞻性评估结构化急诊体液暴露路径。
  • 研究显示接受HIV暴露后预防者中随访计划与一线方案记录较常见,但完整推荐评估与基线检查记录不常见。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate documented adherence to Australian guideline recommendations for emergency department (ED) management of patients receiving human immunodeficiency virus post-exposure prophylaxis (HIV PEP) and explore variation by exposure category.

METHODS: A retrospective, dual-site cohort study included consecutive patients dispensed HIV PEP at two Australian EDs between 1 June 2020 and 1 June 2025. Patients with known HIV infection or managed through a dedicated sexual assault pathway were excluded. Records were reviewed for documented exposure-risk assessment, applicable baseline investigations, antiretroviral regimen, counselling, discharge information and clinician-documented follow-up plan or referral. Exploratory comparisons were undertaken by exposure category.

RESULTS: Seventy-seven patients were included. Clinician documented follow-up plan or referral was documented in 73 (94.8%), and 61 (79.2%) received the first-line regimen recommended by the applicable guidance. Complete recommended management was documented in 8 (10.4%), exposure-risk assessment in 36 (46.8%) and complete baseline investigations in 10 (13.0%). Compared with occupational and other community exposures, consensual sexual exposures had lower documented exposure-risk assessment (36.2% vs. 78.9%; OR: 0.16, 95% CI: 0.03-0.57) and complete baseline investigations (5.2% vs. 36.8%; OR: 0.10, 95% CI: 0.01-0.50).

CONCLUSIONS: Among patients dispensed HIV PEP, recommended regimens and follow-up were commonly documented, but complete recommended assessment and investigation were uncommon. A structured ED body-fluid exposure pathway should be prospectively evaluated.

来源:Emerg Med Australas,查看原文。版权归原作者所有。

参考来源

  1. MacIvor L, Evans E, Keijzers G, et al. Emergency Department Management of Body-Fluid Exposures Receiving Human Immunodeficiency Virus Post-Exposure Prophylaxis: Adherence to Australian Guideline Recommendations. Emerg Med Australas. 2026. PMID: 42995147. doi:10.1111/1742-6723.70390

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。